Simões, E. A. F., Forleo-Neto, E., Geba, G. P., Kamal, M., Yang, F., Cicirello, H., Houghton, M. R., Rideman, R., Zhao, Q., Benvin, S. L., Hawes, A., Fuller, E. D., Wloga, E., Pizarro, J. M. N., Munoz, F. M., Rush, S. A., McLellan, J. S., Lipsich, L., Stahl, N., Yancopoulos, G. D., Weinreich, D. M., Kyratsous, C. A., & Sivapalasingam, S. (2021). suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clinical infectious diseases, 73, e4400–e4408. http://access.bl.uk/ark:/81055/vdc_100148043807.0x000032